Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mangoceuticals, Inc. ( (MGRX) ) has shared an announcement.
On June 2 and June 9, 2025, Mangoceuticals, Inc. saw significant warrant exercises and stock conversions, resulting in the issuance of new common stock shares. Abri Advisors Ltd., Clover Crest Bahamas Ltd., and Indigo Capital LP exercised warrants, while a Series B Convertible Preferred Stock conversion also took place, all under exemptions from registration. Additionally, on June 5, 2025, the company executed an Advance Notice under its Equity Purchase Agreement with Platinum Point Capital, selling 100,000 shares for $193,190, further strengthening its financial position.
More about Mangoceuticals, Inc.
Average Trading Volume: 298,091
Technical Sentiment Signal: Sell
Current Market Cap: $22.51M
See more insights into MGRX stock on TipRanks’ Stock Analysis page.